FDA lays out proposal for naming lower-cost biotech - or 'biosimilar' - drugs Story Date: 8/28/2015
Source: WRAL TECHWIRE, 8/28/15
The Food and Drug Administration has released its proposal for naming lower-cost biotech drugs, a critical step in creating a market for the new class of medicines.
